Frontiers in Genetics (Nov 2021)
Association Analysis of WNT3, HLA-DRB5 and IL1R2 Polymorphisms in Chinese Patients With Parkinson’s Disease and Multiple System Atrophy
- Wei-Ming Su,
- Wei-Ming Su,
- Wei-Ming Su,
- Xiao-Jing Gu,
- Xiao-Jing Gu,
- Xiao-Jing Gu,
- Yan-Bing Hou,
- Yan-Bing Hou,
- Yan-Bing Hou,
- Ling-Yu Zhang,
- Ling-Yu Zhang,
- Ling-Yu Zhang,
- Bei Cao,
- Bei Cao,
- Bei Cao,
- Ru-Wei Ou,
- Ru-Wei Ou,
- Ru-Wei Ou,
- Ying Wu,
- Ying Wu,
- Ying Wu,
- Xue-Ping Chen,
- Xue-Ping Chen,
- Xue-Ping Chen,
- Wei Song,
- Wei Song,
- Wei Song,
- Bi Zhao,
- Bi Zhao,
- Bi Zhao,
- Hui-Fang Shang,
- Hui-Fang Shang,
- Hui-Fang Shang,
- Yong-Ping Chen,
- Yong-Ping Chen,
- Yong-Ping Chen
Affiliations
- Wei-Ming Su
- Department of Neurology, West China Hospital, Sichuan University, Chengdu, China
- Wei-Ming Su
- Laboratory of Neurodegenerative Disorders, West China Hospital, Sichuan University, Chengdu, China
- Wei-Ming Su
- Rare Disease Center, West China Hospital, Sichuan University, Chengdu, China
- Xiao-Jing Gu
- Department of Neurology, West China Hospital, Sichuan University, Chengdu, China
- Xiao-Jing Gu
- Laboratory of Neurodegenerative Disorders, West China Hospital, Sichuan University, Chengdu, China
- Xiao-Jing Gu
- Rare Disease Center, West China Hospital, Sichuan University, Chengdu, China
- Yan-Bing Hou
- Department of Neurology, West China Hospital, Sichuan University, Chengdu, China
- Yan-Bing Hou
- Laboratory of Neurodegenerative Disorders, West China Hospital, Sichuan University, Chengdu, China
- Yan-Bing Hou
- Rare Disease Center, West China Hospital, Sichuan University, Chengdu, China
- Ling-Yu Zhang
- Department of Neurology, West China Hospital, Sichuan University, Chengdu, China
- Ling-Yu Zhang
- Laboratory of Neurodegenerative Disorders, West China Hospital, Sichuan University, Chengdu, China
- Ling-Yu Zhang
- Rare Disease Center, West China Hospital, Sichuan University, Chengdu, China
- Bei Cao
- Department of Neurology, West China Hospital, Sichuan University, Chengdu, China
- Bei Cao
- Laboratory of Neurodegenerative Disorders, West China Hospital, Sichuan University, Chengdu, China
- Bei Cao
- Rare Disease Center, West China Hospital, Sichuan University, Chengdu, China
- Ru-Wei Ou
- Department of Neurology, West China Hospital, Sichuan University, Chengdu, China
- Ru-Wei Ou
- Laboratory of Neurodegenerative Disorders, West China Hospital, Sichuan University, Chengdu, China
- Ru-Wei Ou
- Rare Disease Center, West China Hospital, Sichuan University, Chengdu, China
- Ying Wu
- Department of Neurology, West China Hospital, Sichuan University, Chengdu, China
- Ying Wu
- Laboratory of Neurodegenerative Disorders, West China Hospital, Sichuan University, Chengdu, China
- Ying Wu
- Rare Disease Center, West China Hospital, Sichuan University, Chengdu, China
- Xue-Ping Chen
- Department of Neurology, West China Hospital, Sichuan University, Chengdu, China
- Xue-Ping Chen
- Laboratory of Neurodegenerative Disorders, West China Hospital, Sichuan University, Chengdu, China
- Xue-Ping Chen
- Rare Disease Center, West China Hospital, Sichuan University, Chengdu, China
- Wei Song
- Department of Neurology, West China Hospital, Sichuan University, Chengdu, China
- Wei Song
- Laboratory of Neurodegenerative Disorders, West China Hospital, Sichuan University, Chengdu, China
- Wei Song
- Rare Disease Center, West China Hospital, Sichuan University, Chengdu, China
- Bi Zhao
- Department of Neurology, West China Hospital, Sichuan University, Chengdu, China
- Bi Zhao
- Laboratory of Neurodegenerative Disorders, West China Hospital, Sichuan University, Chengdu, China
- Bi Zhao
- Rare Disease Center, West China Hospital, Sichuan University, Chengdu, China
- Hui-Fang Shang
- Department of Neurology, West China Hospital, Sichuan University, Chengdu, China
- Hui-Fang Shang
- Laboratory of Neurodegenerative Disorders, West China Hospital, Sichuan University, Chengdu, China
- Hui-Fang Shang
- Rare Disease Center, West China Hospital, Sichuan University, Chengdu, China
- Yong-Ping Chen
- Department of Neurology, West China Hospital, Sichuan University, Chengdu, China
- Yong-Ping Chen
- Laboratory of Neurodegenerative Disorders, West China Hospital, Sichuan University, Chengdu, China
- Yong-Ping Chen
- Rare Disease Center, West China Hospital, Sichuan University, Chengdu, China
- DOI
- https://doi.org/10.3389/fgene.2021.765833
- Journal volume & issue
-
Vol. 12
Abstract
Background: The association between inflammation and neurodegeneration has long been observed in parkinson’s disease (PD) and multiple system atrophy (MSA). Previous genome-wide association studies (GWAS) and meta-analyses have identified several risk loci in inflammation-associated genes associated with PD.Objective: To investigate whether polymorphisms in some inflammation-associated genes could modulate the risk of developing PD and MSA in a Southwest Chinese population.Methods: A total of 2,706 Chinese subjects comprising 1340 PD, 483 MSA and 883 healthy controls were recruited in the study. Three polymorphisms (rs2074404 GG/GT/TT, rs17425622 CC/CT/TT, rs34043159 CC/CT/TT) in genes linked to inflammation in all the subjects were genotyped by using the Sequenom iPLEX Assay.Results: The allele G of WNT3 rs2074404 can increase risk on PD (OR: 1.048, 95% CI: 1.182–1.333, p = 0.006), exclusively in the LOPD subgroup (OR: 1.166, 95% CI:1.025–1.327, p = 0.019), but not in EOPD or MSA. And the recessive model analysis also demonstrated an increased PD risk in GG genotype of this locus (OR = 1.331, p = 0.007). However, no significant differences were observed in the genotype distributions and alleles of HLA-DRB5 rs17425622 and IL1R2 rs34043159 between the PD patients and controls, between the MSA patients and controls, or between subgroups of PD or MSA and controls.Conclusion: Our results suggested the allele G of WNT3 rs2074404 have an adverse effect on PD and particularly, on the LOPD subgroup among a Chinese population.
Keywords
